Effect of Sacubitril/Valsartan vs Valsartan on Left Atrial Volume in Patients With Pre–Heart Failure With Preserved Ejection Fraction: The PARABLE Randomized Clinical Trial

IMPORTANCE: Pre–heart failure with preserved ejection fraction (pre-HFpEF) is common and has no specific therapy aside from cardiovascular risk factor management. OBJECTIVE: To investigate the hypothesis that sacubitril/valsartan vs valsartan would reduce left atrial volume index using volumetric ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Ledwidge, Mark, Dodd, Jonathan D., Ryan, Fiona, Sweeney, Claire, McDonald, Katherine, Fox, Rebecca, Shorten, Elizabeth, Zhou, Shuaiwei, Watson, Chris, Gallagher, Joseph, McVeigh, Niall, Murphy, David J., McDonald, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996460/
https://www.ncbi.nlm.nih.gov/pubmed/36884247
http://dx.doi.org/10.1001/jamacardio.2023.0065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996460/
https://www.ncbi.nlm.nih.gov/pubmed/36884247
http://dx.doi.org/10.1001/jamacardio.2023.0065

Ejemplares similares